White adipose tissue (WAT) is the most prevalent form of fat in the human body. While it plays a major role in energy storage, it also has significant endocrine functions, including producing leptin, adiponectin, TNF-alpha, aromatase, and other adipokines discussed in prior blogs. In this post, we will focus on the metabolic potential of brown adipose tissue (BAT) and the emerging concept of “beiging,” which is the induction of brown-like properties in white adipocytes.
Brown adipose tissue was once thought to exist only in infants, but we now know that BAT persists in adults and may even be inducible. BAT differs from WAT in several ways. First, it contains numerous mitochondria, which gives it its darker color due to high iron content. It also has multiple small lipid droplets, in contrast to the single large droplet seen in WAT. These features make BAT more metabolically active and structurally denser.
Within the mitochondrial inner membrane of BAT lies uncoupling protein 1 (UCP1). This protein disrupts ATP synthesis by allowing protons to leak across the membrane, releasing energy as heat, a process known as non-shivering thermogenesis. This is typically an inefficient energy use pathway, but in the context of obesity, this inefficiency can be leveraged to increase basal metabolic rate and total energy expenditure, with potential improvements in glycemic control and lipid profiles.
BAT activation is sympathetically mediated, often triggered by cold exposure. A landmark study published in the New England Journal of Medicine demonstrated that brief cold exposure (e.g., an ice water foot bath) led to a 15-fold increase in glucose uptake by BAT in adults, verified through nuclear imaging and biopsy. However, this increased energy expenditure did not lead to significant or sustained weight loss, likely due to physiologic adaptation and compensatory hyperphagia.
Given the potential positive benefits of BAT, several pharmacologic agents and research avenues have been explored to mimic cold-induced thermogenesis:
- β3-adrenergic agonists like mirabegron (used for overactive bladder) have been shown to activate BAT at higher doses. However, these high doses are associated with hypertension and cardiovascular side effects, limiting clinical utility.
- Capsaicin analogs have demonstrated modest BAT activation in trials, though with limited impact on weight loss.
- FGF-21 analogs and receptor-binding protein agonists have shown promise in improving lipid profiles and insulin sensitivity, but with minimal glucose-lowering effects and negligible weight loss, likely due to metabolic compensation.
- Leptin increases glucose uptake in both muscle and BAT, but the only known way to significantly increase leptin is to increase WAT, which undermines its utility as a therapeutic target. Pharmacologic leptin analogues, such as metreleptin, have not been well studied outside of congenital leptin deficiency, and the high cost of treatment likely remains a limiting factor.
Another interest is the process of converting white adipocytes to resemble brown fat, known as “beiging,” which is a promising area of research. Beige adipocytes express UCP1 and can contribute to thermogenesis and energy expenditure. Potential agents being investigated for inducing beiging include:
- Beta-aminoisobutyric acid
- PPAR agonists
- JAK inhibitors
- Irisin
- Musclin
- Transcription factor A, mitochondrial
Even some functional foods, such as conjugated linoleic acid, have been proposed to activate beige fat, though sustained and clinically significant weight loss has not been demonstrated.
Not all strategies aimed at increasing thermogenesis are safe. For example, 2,4- dinitrophenol, an unregulated mitochondrial uncoupler, can cause life-threatening hyperthermia due to uncontrolled heat production. This underscores the importance of carefully balancing efficacy and safety in BAT-targeting interventions.
While there are currently no FDA-approved anti-obesity medications specifically designed to activate BAT or induce beiging, the field is rapidly evolving. Understanding the physiology of BAT and its potential role in energy expenditure, metabolic regulation, and future therapeutics is high-yield for the ABOM exam. Know how BAT differs from WAT in structure and function, understand the role of UCP1 and non-shivering thermogenesis, be familiar with cold exposure, β3-agonists, and FGF-21 analogs as potential BAT activators, and recognize the limitations of current strategies, including physiologic adaptation and side effect profiles.
Sample Question
A recent medication has been found to increase adipose tissue that contains significantly more mitochondria. If studied further, what quality would this adipose tissue display?
A. Mechanically inefficient
B. Reduces core body temperature
C. Promotes energy expenditure through shivering
D. Suppresses metabolic rate proportionately
Next Week: Monthly Knowledge Check. This is a review checklist of must-know items for ABOM exams based on the previous four blog topics (VLCD, antibiotics and ACE, underwater weighing, and brown/beige adiposity). In addition, this will include a brief explanation of the correct answers to previous sample questions.
Following Week: ASN (nephrology) guidelines (an ABOM-recommended resource)
Upcoming: Functional foods, preoperative evaluation, and pediatric challenges (bullying, stigma, and food insecurity)
For more practice questions, check out the following:
- Obesity Medicine Board Review Questions (2026): Q 67.
- Obesity Medicine Practice Tests (2026): Q 429.
(Copyright 2026) Obesity Medicine Board Review Questions, LLC: obesitymedicinereview.com
Featured image: Modified from VectorStock (image license purchased)
Copyediting by Kelly Smith
Now available: A full line of ABOM study resources with 775+ challenging questions in a mobile or book format. Access to both formats is available in a discounted Ultimate Package, which also includes a Pass Guarantee (if you fail the exam in 2026, you get the 2027 edition free), 50 bonus questions released in August, and the newest book, Obesity Medicine: Sample Questions and Study Blogs, which includes all the updated previous study blogs in a paperback format. Check it out here!
